Hematology NewsEx–hospital porter a neglected giant of cancer researchMay 11, 2022ALLAggressive LymphomasB Cell LymphomaCLLDLBCLMantle Cell LymphomaMultiple Myeloma
Hematology NewsFirst-line CAR T-cell therapy could help cure some lymphomasMarch 22, 2022Aggressive LymphomasDLBCLGene Therapy
Hematology NewsRepurposed drug could revolutionize stem cell transplantationMarch 18, 2022TransplantB Cell LymphomaHodgkin LymphomaMultiple MyelomaPediatricsDLBCLCLL
Hematology NewsEMA gives green light to new CAR T-cell therapyFebruary 3, 2022DLBCLB Cell LymphomaCellular Therapy
Hematology News100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'January 21, 2022TransplantAggressive LymphomasALLDLBCLCLLTranslational ResearchB Cell Lymphoma
Oncology PracticeRituximab and COVID-19 vaccines: Studies begin to answer key questionsJanuary 21, 2022COVID-19 UpdatesLymphoma & Plasma Cell DisordersCLLB Cell LymphomaDLBCL
Hematology NewsDKMS: Small nonprofit to world’s largest stem cell donor registryJanuary 21, 2022ALLCOVID-19 UpdatesMixed TopicsMultiple MyelomaDLBCLB Cell LymphomaAML
Hematology NewsIn some lymphomas, ibrutinib yields “almost unheard-of” survival ratesDecember 8, 2021DLBCLB Cell Lymphoma
Hematology NewsEasing access to DLBCL treatments: Patient study reveals racial differencesNovember 17, 2021DLBCLB Cell Lymphoma
Hematology NewsNew trials in lymphoma and MM: Could your patient benefit?November 10, 2021DLBCLMantle Cell LymphomaB Cell Lymphoma
Hematology NewsOn improving DLBCL outcomes, single-agent regimens fall shortOctober 20, 2021DLBCLB Cell Lymphoma
Hematology NewsCOVID boosters help protect blood cancer patients, but some still vulnerableSeptember 30, 2021DLBCL
Hematology NewsReal-world CAR T outcomes for DLBCL mimic clinical trialsJune 28, 2021DLBCLB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsExperimental antibody-drug conjugate shown active against r/r DLBCLJune 15, 2021B Cell LymphomaDLBCLLymphoma & Plasma Cell Disorders
